HEALTH. BUSINESS. LEGALIZATION.
THE TIME HAS COME
The August 2020 landmark decision by Health Canada allowing four terminally ill patients to use psilocybin signals a shift in the perception of psychedelics as a legitimate medical and therapeutic solution. Combined with a growing interest in the space among the general public and the emergence of companies engaged in everything from legal ketamine administration to R&D around various other medical psychedelic interventions, the run up to some form of legalization and explosive growth in the sector is imminent.
The psychedelic revolution has begun and we are ready to televise it.
10AM — 12PM
THE RESEARCH — PSYCHEDELICS & TRANSFORMATIONAL IMPACT
The opening session of the day will recap the latest findings in key areas of psychedelic research spanning psilocybin, DMT, ketamine, ibogaine, and more, with some of the top minds in the space taking the stage. Hear about the role psychedelic interventions can play in treating mental health and addiction, as well as the profound impact of psychedelic therapy in addressing our own mortality
12:45PM — 2PM
LEGALIZATION & THE BUSINESSES DRIVING IT
Meet some of the brands that will define the future of psychedelics in the years to come. This session will present some of the people and companies that are at the forefront of making psychedelic interventions accessible to the broader public. The rubber meets the road as we get into everything from scaling for patient access to navigating the journey to legalization.
2:15PM — 4PM
We close the day off with a session on the effects of psychedelic interventions that have been at the center of religious and healing practices for hundreds of years. We’ll hear from authors, retreat leaders and skilled microdosers about their first hand experiences on the broad spectrum of impacts that psychedelics can have, from treating anxiety and depression to creating encounters with a higher consciousness.